qPCR試薬の世界市場予測（～2020）...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Factor Analysis
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Healthcare Expenditure Patterns
2.2.2.2 Rapid Growth of Aging Population
2.2.2.3 Incidence and Prevalence of Cancer
2.2.2.4 Birth Rate/Pregnancies
2.2.2.5 Burden of Infectious Diseases
2.2.2.6 Number of Clinical, Forensic, and Research Laboratories
2.2.3 Supply-Side Analysis
2.2.3.1 Number of New Product Launches: qPCR Reagents vs. Competitive Technologies
2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.5.1 Assumptions

3 Executive Summary (Page No. – 34)
3.1 Introduction
3.2 History, Evolution, and Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 39)
4.1 Global qPCR Reagents Market (2015–2020)
4.2 Global Market Size, By Detection Method (2015 vs. 2020)
4.3 Global Market Share, By Packaging Type (2015)
4.4 Global Market Size, By Application (2015)
4.5 Global Market Size, By End User (2015 vs. 2020)

5 Market Overview (Page No. – 44)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Key Market Drivers
5.3.1.1 Rising Incidence of Infectious Diseases and Genetic Disorders
5.3.1.2 Growing Geriatric Population
5.3.1.3 Technological Advancements
5.3.1.4 Increasing Public-Private Investments, Funds, and Grants
5.3.1.5 Successful Completion of the Human Genome Project
5.3.2 Key Market Restraints
5.3.2.1 Technical Limitations Associated With qPCR
5.3.3 Key Market Opportunities
5.3.3.1 Growing Market Penetration in Emerging Countries
5.3.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
5.3.4 Key Market Challenges
5.3.4.1 Adoption and Implementation of Miqe Guidelines for Publishing qPCR-Based Research

6 Industry Trends (Page No. – 53)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.4 Industry Trends
6.5 Porter’s Five Forces Analysis
6.5.1 Threat From New Entrants
6.5.2 Threat From Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry

7 qPCR Reagents Market, By Detection Method (Page No. – 58)
7.1 Introduction
7.2 Dye-Based qPCR Reagents
7.3 Probes and Primer-Based qPCR Reagents

8 qPCR Reagents Market, By Packaging Type (Page No. – 62)
8.1 Introduction
8.2 qPCR Core Kits
8.3 qPCR Mastermixes

9 qPCR Reagents Market, By End User (Page No. – 67)
9.1 Introduction
9.2 Hospitals & Diagnostic Centers
9.3 Research Laboratories & Academic Institutes
9.4 Pharmaceutical & Biotechnology Companies
9.5 Clinical Research Organizations (Cros)
9.6 Forensic Laboratories

10 qPCR Reagents Market, By Application (Page No. – 74)
10.1 Introduction
10.2 Diagnostic Applications
10.3 Research Applications
10.4 Forensic Applications

11 qPCR Reagents Market, By Region (Page No. – 79)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Rest of Europe (RoE)
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. – 107)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.4 Recent Developments
12.4.1 New Product Launches and Product Approvals
12.4.2 Agreements, Collaborations, and Partnerships
12.4.3 Mergers, Demergers, and Acquisitions
12.4.4 Expansion

13 Company Profiles (Page No. – 114)
13.1 Introduction
13.1.1 Geographic Benchmarking
13.1.2 Strategic Benchmarking
13.1.2.1 Product Development and Commercialization
13.2 Thermo Fisher Scientific Inc.
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM Overview
13.3 Bio-Rad Laboratories, Inc.
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM Overview
13.4 F. Hoffman-La Roche Ltd.
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM Overview
13.5 Qiagen N.V.
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM Overview
13.6 Agilent Technologies, Inc.
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM Overview
13.7 Takara Bio Inc.
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 Affymetrix, Inc.
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 Sigma-Aldrich Corporation (A Subsidiary of Merck Kgaa, Germany)
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.10 Promega Corporation
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Quanta Biosciences, Inc.
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Recent Developments

14 Appendix (Page No. – 150)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Introducing RT: Real Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports